North Korea's new drug claims to beat 'deadly ' MERS, Ebola, Sars, AIDS

Image
ANI Washington
Last Updated : Jun 20 2015 | 4:22 PM IST

Seems like fortunes are turning better for North Korea as the country recently announced that they have created a drug that can allegedly both cure and prevent MERS, Ebola, Sars and AIDS.

The official Korean Central News Agency announced that malicious virus infections were related to immune systems, so they could be easily treated by Kumdang-2 injection drug, which is a strong immune reviver, reported E! Online.

However, despite of the big announcement, no proof of the miracle cure has been provided, triggering skepticism among many.

North Korea's claim comes as rival country South Korea is battling an intense outbreak of the Middle East respiratory syndrome (Mers).

But, despite the virus' spread to Eastern Asia, Kwon Deok-cheol, an official with the Ministry of Health and Welfare leading MERS task force said that looking at the current trend; they have judged that situation has leveled off.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 20 2015 | 4:04 PM IST

Next Story